全文获取类型
收费全文 | 1837篇 |
免费 | 142篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 91篇 |
妇产科学 | 37篇 |
基础医学 | 287篇 |
口腔科学 | 36篇 |
临床医学 | 179篇 |
内科学 | 341篇 |
皮肤病学 | 49篇 |
神经病学 | 69篇 |
特种医学 | 138篇 |
外科学 | 196篇 |
综合类 | 67篇 |
一般理论 | 1篇 |
预防医学 | 124篇 |
眼科学 | 18篇 |
药学 | 143篇 |
中国医学 | 2篇 |
肿瘤学 | 194篇 |
出版年
2021年 | 19篇 |
2020年 | 17篇 |
2019年 | 24篇 |
2018年 | 19篇 |
2017年 | 21篇 |
2016年 | 20篇 |
2015年 | 34篇 |
2014年 | 47篇 |
2013年 | 52篇 |
2012年 | 37篇 |
2011年 | 38篇 |
2010年 | 62篇 |
2009年 | 53篇 |
2008年 | 37篇 |
2007年 | 52篇 |
2006年 | 38篇 |
2005年 | 47篇 |
2004年 | 41篇 |
2003年 | 37篇 |
2002年 | 32篇 |
2001年 | 31篇 |
2000年 | 49篇 |
1999年 | 41篇 |
1998年 | 55篇 |
1997年 | 43篇 |
1996年 | 43篇 |
1995年 | 34篇 |
1994年 | 45篇 |
1993年 | 45篇 |
1992年 | 29篇 |
1991年 | 38篇 |
1990年 | 33篇 |
1989年 | 55篇 |
1988年 | 61篇 |
1987年 | 59篇 |
1986年 | 40篇 |
1985年 | 40篇 |
1984年 | 34篇 |
1983年 | 40篇 |
1982年 | 31篇 |
1981年 | 21篇 |
1980年 | 23篇 |
1979年 | 26篇 |
1978年 | 33篇 |
1977年 | 35篇 |
1974年 | 25篇 |
1973年 | 32篇 |
1972年 | 27篇 |
1970年 | 24篇 |
1966年 | 20篇 |
排序方式: 共有1994条查询结果,搜索用时 46 毫秒
1.
2.
3.
4.
GP SCHWAB AL BLUM E BODNER B DALLEMAGNE K GLASER H KOOP F PACE W RÖSCH JR SIEWERT G WETSCHER 《Journal of gastroenterology and hepatology》1997,12(12):785-789
Gastroesophageal reflux disease (GERD) is the most common disease of the upper gastrointestinal tract. With the introduction of proton pump inhibitors medical treatment of GERD has been significantly improved. However, the development of laparoscopic antireflux surgery resulted in an increasing interest of surgeons in this disease. An interactive meeting was organized in order to develop an agreement between gastoenterologists and surgeons regarding therapeutic decisions and this is the main topic of this paper. 相似文献
5.
John Lister 《Sociology of health & illness》2006,28(7):992-995
6.
T. Hickish P. Serafinowski D. Cunningham A. Oza E. Dorland I. Judson B. C. Millar T. A. Lister A. Roldan 《British journal of cancer》1993,67(1):139-143
2''-Chlorodeoxyadenosine (2CDA) is a purine analogue selectively active against both resting and dividing lymphoid cells. Twenty-one patients with a variety of previously treated lymphoid malignancies received a total of 41 courses of 2CDA (0.1-0.15 mg/kg/day over 7 days continuous intravenous infusion) on compassionate grounds. The profile of the patient population was as follows: low grade non-Hodgkin''s lymphoma (NHL) = 8, intermediate grade NHL = 2, transformed (intermediate grade NHL) = 6, Hodgkin''s disease = 1, lymphoplasmacytoid NHL = 3 and lymphoblastic NHL = 1. The overall response rate was 53%, with three patients attaining complete remission (CR) and eight partial remission (PR). Three of 16 patients with primary resistant or resistant recurrent disease entered either CR (1) or PR (2). Ten patients had no response or progressive disease. The latter group was comprised of patients who had extensively pre-treated lymphoplasmacytoid tumours and/or poor performance status (WHO grades 2-4). The median duration of response is 6 months (range 1 to 12 months). Treatment was well tolerated and the chief toxicities were leucopenia and thrombocytopenia which were most pronounced when there was bone marrow involvement. As a result of dose limiting myelotoxicity, a dose escalation to 0.15 mg/kg/day was possible on just three occasions. These data confirm other reports of the activity of 2CDA in low grade NHL and indicate it may have activity in Hodgkin''s disease. There was no demonstrable activity in poor performance status patients or those with extensively pre-treated lymphoplasmacytoid tumours. 相似文献
7.
8.
9.
T S Ganesan H S Dhaliwal M S Dorreen A G Stansfeld J A Habeshaw T A Lister 《British journal of cancer》1987,55(4):437-442
Twenty four patients with angio-immunoblastic lymphadenopathy (AILD) presenting between 1974 and 1985 have been reviewed. Clinical features at presentation included rash, fever, lymphadenopathy and hepatosplenomegaly in 75% of patients. Polyclonal hypergammaglobulinaemia was seen in 19/20 patients; 5 had normal immunoglobulin levels. Combination chemotherapy with MVPP was the optimal treatment with 6/7 patients achieving complete remission. Duration of remission ranged from 9 months to 4 years and was significantly longer in patients achieving complete as opposed to partial remission. In 6 patients phenotype studies were performed on single cell suspensions and immunoperoxidase studies on frozen sections of 7 lymph nodes. There was a reversal of the normal T suppressor/helper cell ratio with a predominance of T suppressor cells. Loss of normal B follicles was observed histologically in all except one lymph node. Germline configuration of the beta B-chain of the T cell receptor was observed in lymph nodes of 4 patients with AILD, and a rearranged T cell receptor was observed in 1 patient in whom a second lymph node biopsy had shown alteration of the histological picture to that of T-zone lymphoma. Frozen sera of 15 patients were screened for antibodies to HTLV I and III and were found to be negative. 相似文献
10.